Opdivo
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Opdivo in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Opdivo.
10
Global Revenue Ranking
21
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Opdivo
Almost one million new cases of gastric cancer are diagnosed globally every year
‘Hot’ tumours, breast cancer breakthroughs and holistic treatment were the standouts at this year’s event
Up to 55% of patients with non-metastatic NSCLC develop recurrence despite curative resection
The new formulation reduces administration time from 30-to-60 minutes to three-to-five minutes
Approximately 44,000 people are diagnosed with colorectal cancer in the UK every year
Around 42,240 people are expected to be diagnosed with liver cancer in the US this year
More than 154,000 cases of the disease are expected to be diagnosed in the US this year
Up to 55% of non-metastatic NSCLC patients will develop disease recurrence despite surgical resection
The disease accounts for up to 30% of non-Hodgkin lymphoma cases
More than 866,100 cases of the disease were diagnosed globally in 2022
More than 200,000 people are diagnosed with lung cancer in the US every year
The disease is the second most common form of non-Hodgkin lymphoma, accounting for up to 30% of cases
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology